DDD Partners’s Pfizer PFE Stock Holding History

DDD Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-32,237	Closed	-$817K	–	121
2025 Q1	$817K	Buy	+32,237	New	+$844K	0.1%	60
2024 Q4	–	Sell	-7,904	Closed	-$229K	–	106
2024 Q3	$229K	Buy	+7,904	New	+$231K	0.02%	96
2023 Q2	–	Sell	-5,335	Closed	-$218K	–	92
2023 Q1	$218K	Buy	5,335 +20	+0.4%	+$864	0.03%	74
2022 Q4	$272K	Sell	5,315 -57	-1%	-$2.73K	0.04%	67
2022 Q3	$235K	Sell	5,372 -90	-2%	-$4.37K	0.04%	76
2022 Q2	$286K	Buy	5,462 +147	+3%	+$7.49K	0.05%	71
2022 Q1	$275K	Hold	5,315	–	–	0.04%	73
2021 Q4	$314K	Buy	+5,315	New	+$263K	0.04%	75

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

DDD Partners's PFE Position: Q2 2025 in Review

DDD Partners sold out of Pfizer (PFE) in Q2 2025, closing a stake of 32,237 shares — an estimated $817K sold.

DDD Partners first reported a position in PFE in Q4 2021 and held it in 8 quarters. The position peaked at $817K in Q1 2025. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

DDD Partners reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
DDD Partners sold 32,237 Pfizer shares in Q2 2025, an estimated $817K.
DDD Partners first reported a position in Pfizer in Q4 2021 and held it in 8 quarters.
DDD Partners's Pfizer position peaked at $817K in Q1 2025.
2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on DDD Partners's 13F filing for Q2 2025, filed 31 Jul 2025.